New anti-TB drug with active ingredient Pretomanid gets FDA approval
-
Last Update: 2020-06-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently, it was reported that the new anti-TBnew drug(http://) funded by BMBF and active ingredient pretomanid was approved
by the http://Administration (
FDA(http://Pretomanid is part of the BPaL program with Bedaquilin and Linezolid, targeting patients with MDR-TB who are widely resistant to tb or cannot be toleratedPretomanid is the third new anti-TB drug approved for the market in nearly half a centuryPrior to that, Johnson and Johnson's multidrug-resistant TB drug Bedaquin was approved by the FDA and the European Medicines Agency (EMA) in 2012 and 2013, respectively, and Dramani, of OtsukaPharmaceutical(http://, received conditional approval from the European EMA for the treatment of MDRTB at the end of 2013The BMBF said the effectiveness and safety of the BPaL programme had beenand verified in clinicaltrials in 19 hospitals in 14 countries
http:// The results showed that the cure rate increased from 35% to more than 90%, the treatment period was shortened from 18 months to 6 months, and the of the drug (http:// was changed from injection to oral Researchers are currently testing the efficacy of Pretomanid with different drug combinations in order to develop a relatively simple and inexpensive treatment for all TB patients as soon as possible
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
